We are looking forward to hearing about the impressive work being done in our field during this year’s clinical session and you don’t want to miss out! The talks will be live on September 30 from 2:30-4:30 pm EST and also available on-demand upon the conclusion of the session. The session Co-Chairs, James Hamilton, MD, MBA, Vice President Clinical Development and Head of Corporate Development at Arrowhead Pharmaceuticals and Arthur M. Krieg, MD Founder and CSO of Checkmate Pharmaceuticals, will be leading this riveting session. You won’t want to miss your chance to learn directly from the experts as they discuss these intriguing topics:
• Antisense Therapies for Lipid Disorders
Sotirios (Sam) Tsimikas, MD, FACC, FAHA, FSCAI, Senior Vice President of Global Cardiovascular Development at Ionis Pharmaceuticals and Professor of Medicine and the Director of Vascular Medicine at the University of California San Diego School of Medicine
• Human Translation of GalNAc-siRNA Conjugates with Improved Specificity
Vasant Jadhav, Ph.D., Senior Director of Research at Alnylam Pharmaceuticals
• VIR-2218, an X-targeted siRNA for the Functional Cure of HBV
Phil Pang, M.D., Ph.D., Chief Medical Officer at Vir Biotechnology, Inc.
• Chronic Liver-Specific LDHA Suppression in the Treatment of Primary Hyperoxaluria: Evaluating the Safety and Efficacy of the Investigational Therapy, Nedosiran
Kerry S. Russell, MD, Ph.D. Head of Late Stage Clinical Development at Dicerna Pharmaceuticals, Inc. and Bob Brown, Ph.D., Senior Vice President of Research at Dicerna Pharmaceuticals, Inc.
• TRiM Platform Derived siRNA Therapeutics: Targeting Hepatocytes and Beyond
James Hamilton, MD, MBA, Vice President Clinical Development and Head of Corporate Development at Arrowhead Pharmaceuticals
If you would like to discover more about any of these outstanding experts that we will be it’s not too late to register for this year’s exceptional meeting. Here are the links to discover more about this year’s Annual Meeting, and Fees, check out the FAQs, and Register. We hope that you will join us!
We are also excited to welcome have a powerful group of 15 exhibitors representing 3 continents to this year’s virtual meeting.
